TABLE 4.
Treatment | Production (pg/ml) of cytokineb:
|
|||
---|---|---|---|---|
IL-1α | IL-1β | TNF-α | TGF-β | |
None | 0 | 0 | 0 | 0 |
LPS (1 μg/ml) | 376 ± 123 | 877 ± 233 | 543 ± 156 | 433 ± 203 |
Ethanol | ||||
25 mM | 250 ± 84 | 595 ± 170 | 375 ± 97 | 180 ± 57 |
75 mM | 165 ± 54 | 275 ± 84 | 235 ± 84 | 275 ± 135 |
150 mM | 95 ± 34 | 101 ± 30 | 125 ± 70 | 375 ± 70 |
Acetaldehyde | ||||
25 mM | 247 ± 101 | 734 ± 211 | 395 ± 100 | 175 ± 57 |
75 mM | 175 ± 87 | 347 ± 121 | 247 ± 87 | 271 ± 121 |
150 mM | 97 ± 31 | 121 ± 41 | 130 ± 87 | 325 ± 121 |
Acetate | ||||
25 mM | 270 ± 101 | 627 ± 121 | 427 ± 121 | 148 ± 57 |
75 mM | 151 ± 29 | 285 ± 95 | 297 ± 98 | 256 ± 98 |
150 mM | 87 ± 27 | 141 ± 42 | 150 ± 72 | 340 ± 120 |
Significant reductions in IL-1α, IL-1β, and TNF-α production were observed when ethanol-, acetaldehyde-, and acetate-treated LPS-stimulated monocytes were compared with untreated monocytes.
These data represent values of four separate experiments and are expressed as the means ± standard errors.